[
  {
    "ts": null,
    "headline": "Jim Cramer Says “Cardinal Is Really the Monster” Among Drug Distributors",
    "summary": "Cardinal Health, Inc. (NYSE:CAH) is one of the stocks from different market sectors that Jim Cramer commented on. Cramer highlighted the company’s noteworthy performance, as he commented: “The drug distributors continue to relentlessly climb higher. There’s nothing, you know, people hate the pharma middleman. Even the president doesn’t talk, like… them. But I got to […]",
    "url": "https://finnhub.io/api/news?id=8393446f81ca36c9afa07275d33c15d7d0a6033b79f962bc957e26691b516da5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768240073,
      "headline": "Jim Cramer Says “Cardinal Is Really the Monster” Among Drug Distributors",
      "id": 138076639,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MCK",
      "source": "Yahoo",
      "summary": "Cardinal Health, Inc. (NYSE:CAH) is one of the stocks from different market sectors that Jim Cramer commented on. Cramer highlighted the company’s noteworthy performance, as he commented: “The drug distributors continue to relentlessly climb higher. There’s nothing, you know, people hate the pharma middleman. Even the president doesn’t talk, like… them. But I got to […]",
      "url": "https://finnhub.io/api/news?id=8393446f81ca36c9afa07275d33c15d7d0a6033b79f962bc957e26691b516da5"
    }
  },
  {
    "ts": null,
    "headline": "AOP Health’s Rapiblyk™ Now Accessible via Leading US Healthcare Improvement Companies",
    "summary": "John Kimmet General Manager of AOP Health US WILMINGTON, Del., Jan. 12, 2026 (GLOBE NEWSWIRE) -- AOP Health US, LLC announced today that Rapiblyk™ (landiolol) is now more widely available across the United States through Cardinal, Cencora Specialty Distribution, McKesson Corporation, and M&D Specialty Distribution. Hospitals and health systems nationwide can now access Rapiblyk™ through their preferred purchasing channels, enhancing flexibility while expanding the availability of this critical c",
    "url": "https://finnhub.io/api/news?id=61a3682e747fcea2e14081a95b95c4a99359957f36e8bd244046a10458c57eef",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768226400,
      "headline": "AOP Health’s Rapiblyk™ Now Accessible via Leading US Healthcare Improvement Companies",
      "id": 138072438,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MCK",
      "source": "Yahoo",
      "summary": "John Kimmet General Manager of AOP Health US WILMINGTON, Del., Jan. 12, 2026 (GLOBE NEWSWIRE) -- AOP Health US, LLC announced today that Rapiblyk™ (landiolol) is now more widely available across the United States through Cardinal, Cencora Specialty Distribution, McKesson Corporation, and M&D Specialty Distribution. Hospitals and health systems nationwide can now access Rapiblyk™ through their preferred purchasing channels, enhancing flexibility while expanding the availability of this critical c",
      "url": "https://finnhub.io/api/news?id=61a3682e747fcea2e14081a95b95c4a99359957f36e8bd244046a10458c57eef"
    }
  },
  {
    "ts": null,
    "headline": "3 Medical Supplies Stocks That Beat the Market Despite Macro Headwinds",
    "summary": "Cardinal Health, McKesson, and Cencora are showing how scale, specialty focus, and execution can drive market-beating returns despite macro pressure.",
    "url": "https://finnhub.io/api/news?id=04627c1a3f44b1cfe36272e22f70e136a83168f003f99872972a09e914069a3a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768222260,
      "headline": "3 Medical Supplies Stocks That Beat the Market Despite Macro Headwinds",
      "id": 138072439,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MCK",
      "source": "Yahoo",
      "summary": "Cardinal Health, McKesson, and Cencora are showing how scale, specialty focus, and execution can drive market-beating returns despite macro pressure.",
      "url": "https://finnhub.io/api/news?id=04627c1a3f44b1cfe36272e22f70e136a83168f003f99872972a09e914069a3a"
    }
  }
]